射血分数保留的心力衰竭的研究进展  

Research Progress of Heart Failure with Preserved Ejection Fraction

作　　者：任小田 孙磊[1] REN Xiaotian;SUN Lei(Yangzhou University Medical Academy,Yangzhou 225001,Jiangsu,China;Jiangdu People s Hospital of Yangzhou,Yangzhou 225200,Jiangsu,China)

机构地区：[1]扬州大学医学院,江苏扬州225001 [2]扬州市江都人民医院,江苏扬州225200

出　　处：《心血管病学进展》2018年第6期987-990,共4页Advances in Cardiovascular Diseases

摘　　要：射血分数保留的心力衰竭是一个重大的全球公共健康问题,其发生率为1.1%～5.5%,占心力衰竭人数的40%～71%,严重影响了患者的生活质量,同时造成了社会的医疗支出沉重的负担。基于其发病率的持续增长,射血分数保留的心力衰竭在不久将来会成为心力衰竭最常见的表现形式。虽然近10年射血分数保留的心力衰竭的治疗有了发展,但射血分数保留的心力衰竭患者的预后却并没有得到明显改善。现将国内外有关射血分数保留的心力衰竭的诊断及治疗进行简要综述,旨在了解国内外射血分数保留的心力衰竭的诊断及治疗情况,探讨这些研究带来的启示。Heart failure with preserved ejection fraction（HFpEF）has caused a major public health problem across the world,with a prevalence of between 1.1% to 5.5%,accounting for 40% to 71% of heart failure.It seriously affects the patient s quality of life,while simultaneously results in a heavy burden on society s medical expenses.Based on the sustained growth of incidence rate,HFpEF will be the most common form of heart failure in the near future.Although the treatment of HFpEF has developed over the past 10 years,the prognosis of HFpEF patients has not been significantly improved.This is a brief overview of the diagnosis and treatment of HFpEF at home and abroad.The purpose is to study the diagnosis and treatment of HFpEF at home and abroad and to explore the implications of latest research.

关 键 词：射血分数保留的心力衰竭 射血分数保留的心力衰竭的诊断 射血分数保留的心力衰竭的治疗 

分 类 号：R541.6[医药卫生—心血管疾病]